Ubs Oconnor LLC Bicycle Therapeutics PLC Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Ubs Oconnor LLC holds 20,000 shares of BCYC stock, worth $302,400. This represents 0.03% of its overall portfolio holdings.

Number of Shares

20,000

Holding current value

$302,400

% of portfolio

0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.58 - $27.24 $1 Million - $1.39 Million	-51,084 Reduced 58.68%	35,976 $815,000
Q2 2024 Aug 14, 2024	BUY	$20.02 - $24.69 $41,641 - $51,355	2,080 Added 2.45%	87,060 $1.76 Million
Q1 2024 May 15, 2024	BUY	$16.75 - $26.1 $190,598 - $296,991	11,379 Added 15.46%	84,980 $2.12 Million
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $57,160 - $95,482	-4,301 Reduced 5.52%	73,601 $1.33 Million
Q2 2023 Aug 14, 2023	BUY	$18.95 - $28.67 $1.48 Million - $2.23 Million	77,902 New	77,902 $1.99 Billion
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $8,308 - $13,018	415 Added 0.52%	80,719 $1.72 Million
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $258,271 - $417,139	12,679 Added 18.75%	80,304 $0
Q3 2022 Nov 14, 2022	BUY	$17.49 - $28.44 $174,899 - $284,400	10,000 Added 17.35%	67,625 $1.57 Billion
Q2 2022 Aug 12, 2022	BUY	$12.95 - $46.99 $422,493 - $1.53 Million	32,625 Added 130.5%	57,625 $966,000
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $1 Million - $1.49 Million	25,000 New	25,000 $1.1 Million

Others Institutions Holding BCYC

# of Institutions

112

Shares Held

41.2M

Call Options Held

39.6K

Put Options Held

24.6K

Baker Bros. Advisors LP New York, NY

9.4M
Shares

$142 Million
2.28% of portfolio
Deep Track Capital, LP Greenwich, CT

3.55M
Shares

$53.6 Million
2.97% of portfolio
Fcpm Iii Services B.V. Naarden, P7

2.34M
Shares

$35.4 Million
9.09% of portfolio
Ra Capital Management, L.P. Boston, MA

2.25M
Shares

$34.1 Million
0.71% of portfolio
Armistice Capital, LLC New York, NY

1.96M
Shares

$29.6 Million
0.74% of portfolio

View Full List

About BICYCLE THERAPEUTICS plc

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $449M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

More about BCYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account